These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 33554867)
1. Liver Injury Increases the Incidence of HCC following AAV Gene Therapy in Mice. Dalwadi DA; Torrens L; Abril-Fornaguera J; Pinyol R; Willoughby C; Posey J; Llovet JM; Lanciault C; Russell DW; Grompe M; Naugler WE Mol Ther; 2021 Feb; 29(2):680-690. PubMed ID: 33554867 [TBL] [Abstract][Full Text] [Related]
2. Glycogen storage disease type Ia mice with less than 2% of normal hepatic glucose-6-phosphatase-α activity restored are at risk of developing hepatic tumors. Kim GY; Lee YM; Kwon JH; Cho JH; Pan CJ; Starost MF; Mansfield BC; Chou JY Mol Genet Metab; 2017 Mar; 120(3):229-234. PubMed ID: 28096054 [TBL] [Abstract][Full Text] [Related]
3. Enhanced Efficacy and Increased Long-Term Toxicity of CNS-Directed, AAV-Based Combination Therapy for Krabbe Disease. Li Y; Miller CA; Shea LK; Jiang X; Guzman MA; Chandler RJ; Ramakrishnan SM; Smith SN; Venditti CP; Vogler CA; Ory DS; Ley TJ; Sands MS Mol Ther; 2021 Feb; 29(2):691-701. PubMed ID: 33388420 [TBL] [Abstract][Full Text] [Related]
4. Transduction of hepatocellular carcinoma (HCC) using recombinant adeno-associated virus (rAAV): in vitro and in vivo effects of genotoxic agents. Peng D; Qian C; Sun Y; Barajas MA; Prieto J J Hepatol; 2000 Jun; 32(6):975-85. PubMed ID: 10898318 [TBL] [Abstract][Full Text] [Related]
5. Recombinant adeno-associated virus integration sites in murine liver after ornithine transcarbamylase gene correction. Zhong L; Malani N; Li M; Brady T; Xie J; Bell P; Li S; Jones H; Wilson JM; Flotte TR; Bushman FD; Gao G Hum Gene Ther; 2013 May; 24(5):520-5. PubMed ID: 23621841 [TBL] [Abstract][Full Text] [Related]
6. Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectors. Donsante A; Vogler C; Muzyczka N; Crawford JM; Barker J; Flotte T; Campbell-Thompson M; Daly T; Sands MS Gene Ther; 2001 Sep; 8(17):1343-6. PubMed ID: 11571571 [TBL] [Abstract][Full Text] [Related]
7. Selection and evaluation of clinically relevant AAV variants in a xenograft liver model. Lisowski L; Dane AP; Chu K; Zhang Y; Cunningham SC; Wilson EM; Nygaard S; Grompe M; Alexander IE; Kay MA Nature; 2014 Feb; 506(7488):382-6. PubMed ID: 24390344 [TBL] [Abstract][Full Text] [Related]
8. Evaluating the state of the science for adeno-associated virus integration: An integrated perspective. Sabatino DE; Bushman FD; Chandler RJ; Crystal RG; Davidson BL; Dolmetsch R; Eggan KC; Gao G; Gil-Farina I; Kay MA; McCarty DM; Montini E; Ndu A; Yuan J; Mol Ther; 2022 Aug; 30(8):2646-2663. PubMed ID: 35690906 [TBL] [Abstract][Full Text] [Related]
9. Gene therapy prevents hepatic tumor initiation in murine glycogen storage disease type Ia at the tumor-developing stage. Cho JH; Lee YM; Starost MF; Mansfield BC; Chou JY J Inherit Metab Dis; 2019 May; 42(3):459-469. PubMed ID: 30637773 [TBL] [Abstract][Full Text] [Related]
11. Recent advances in various adeno-associated viruses (AAVs) as gene therapy agents in hepatocellular carcinoma. Hadi M; Qutaiba B Allela O; Jabari M; Jasoor AM; Naderloo O; Yasamineh S; Gholizadeh O; Kalantari L Virol J; 2024 Jan; 21(1):17. PubMed ID: 38216938 [TBL] [Abstract][Full Text] [Related]
12. Pretreatment of rAAV-Mediated Expression of Myostatin Propeptide Lowers Type 2 Diabetes Incidence in Yan H; Meng J; Zhang S; Zhuang H; Song Y; Xiao X; Wang DW; Jiang J Hum Gene Ther; 2019 May; 30(5):661-671. PubMed ID: 30526118 [TBL] [Abstract][Full Text] [Related]
13. Integration of adeno-associated virus (AAV) into the genomes of most Thai and Mongolian liver cancer patients does not induce oncogenesis. Schäffer AA; Dominguez DA; Chapman LM; Gertz EM; Budhu A; Forgues M; Chaisaingmongkol J; Rabibhadana S; Pupacdi B; Wu X; Bayarsaikhan E; Harris CC; Ruchirawat M; Ruppin E; Wang XW BMC Genomics; 2021 Nov; 22(1):814. PubMed ID: 34763675 [TBL] [Abstract][Full Text] [Related]
14. Sex significantly influences transduction of murine liver by recombinant adeno-associated viral vectors through an androgen-dependent pathway. Davidoff AM; Ng CY; Zhou J; Spence Y; Nathwani AC Blood; 2003 Jul; 102(2):480-8. PubMed ID: 12637328 [TBL] [Abstract][Full Text] [Related]
15. Targeting adeno-associated virus and adenoviral gene therapy for hepatocellular carcinoma. Wang YG; Huang PP; Zhang R; Ma BY; Zhou XM; Sun YF World J Gastroenterol; 2016 Jan; 22(1):326-37. PubMed ID: 26755879 [TBL] [Abstract][Full Text] [Related]